$TPHS
Trinity Place Holdings Inc.

2022 Q4 Form 10-Q Financial Statement

#000155837022017866 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $10.27M $19.01M
YoY Change -57.98% 676.71%
Cost Of Revenue $1.795M $1.706M
YoY Change -50.24% 136.29%
Gross Profit $8.479M $17.30M
YoY Change -59.32% 1008.26%
Gross Profit Margin 82.53% 91.02%
Selling, General & Admin $1.318M $1.431M
YoY Change 57.47% 17.58%
% of Gross Profit 15.54% 8.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.881M $695.0K
YoY Change 114.73% 71.18%
% of Gross Profit 22.18% 4.02%
Operating Expenses $10.40M $21.02M
YoY Change -56.96% 345.99%
Operating Profit -$1.917M -$2.009M
YoY Change -42.14% -11.3%
Interest Expense -$6.887M -$3.549M
YoY Change 964.45% 412.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.967M -$6.271M
YoY Change 126.38% 348.25%
Income Tax $16.00K $82.00K
% Of Pretax Income
Net Earnings -$8.983M -$6.353M
YoY Change 117.03% 369.9%
Net Earnings / Revenue -87.43% -33.43%
Basic Earnings Per Share -$0.17
Diluted Earnings Per Share -$0.24 -$0.17
COMMON SHARES
Basic Shares Outstanding 36.91M 36.88M
Diluted Shares Outstanding 37.26M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.548M $2.190M
YoY Change -64.08% 138.82%
Cash & Equivalents $1.500M $2.200M
Short-Term Investments
Other Short-Term Assets $2.494M $2.401M
YoY Change 270.58% 175.03%
Inventory
Prepaid Expenses
Receivables $262.0K $78.00K
Other Receivables $163.0K $123.0K
Total Short-Term Assets $4.467M $4.792M
YoY Change -13.78% 142.14%
LONG-TERM ASSETS
Property, Plant & Equipment $65.60M $66.39M
YoY Change -77.46% -78.48%
Goodwill
YoY Change
Intangibles $7.692M $7.877M
YoY Change -8.78% -8.59%
Long-Term Investments $4.400M $4.500M
YoY Change -8.33% -11.76%
Other Assets $223.5M $210.7M
YoY Change 988.41% 1696.13%
Total Long-Term Assets $302.5M $293.0M
YoY Change -11.41% -15.08%
TOTAL ASSETS
Total Short-Term Assets $4.467M $4.792M
Total Long-Term Assets $302.5M $293.0M
Total Assets $306.9M $297.8M
YoY Change -11.44% -14.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.02M $16.66M
YoY Change 6.46% -9.74%
Accrued Expenses $1.037M $1.141M
YoY Change -28.33% -24.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.06M $17.80M
YoY Change 3.85% -10.88%
LONG-TERM LIABILITIES
Long-Term Debt $258.8M $241.1M
YoY Change -4.4% -11.99%
Other Long-Term Liabilities $727.0K $151.0K
YoY Change -36.56% -89.3%
Total Long-Term Liabilities $259.5M $241.2M
YoY Change -4.53% -12.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.06M $17.80M
Total Long-Term Liabilities $259.5M $241.2M
Total Liabilities $279.6M $259.0M
YoY Change -3.98% -12.29%
SHAREHOLDERS EQUITY
Retained Earnings -$56.89M -$47.90M
YoY Change 84.78% 81.86%
Common Stock $145.3M $145.2M
YoY Change 0.42% 5.91%
Preferred Stock
YoY Change
Treasury Stock (at cost) $57.46M
YoY Change 0.52%
Treasury Stock Shares $6.541M
Shareholders Equity $27.34M $38.81M
YoY Change
Total Liabilities & Shareholders Equity $306.9M $297.8M
YoY Change -11.44% -14.18%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$8.983M -$6.353M
YoY Change 117.03% 369.9%
Depreciation, Depletion And Amortization $1.881M $695.0K
YoY Change 114.73% 71.18%
Cash From Operating Activities -$5.477M $6.458M
YoY Change -6.85% 4648.53%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$25.00K
YoY Change -100.0% -99.73%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 -$25.00K
YoY Change -100.0% -99.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.86M -11.15M
YoY Change 488.72% -203.38%
NET CHANGE
Cash From Operating Activities -5.477M 6.458M
Cash From Investing Activities 0.000 -25.00K
Cash From Financing Activities 15.86M -11.15M
Net Change In Cash 10.38M -4.719M
YoY Change -14.87% -265.35%
FREE CASH FLOW
Cash From Operating Activities -$5.477M $6.458M
Capital Expenditures $0.00 -$25.00K
Free Cash Flow -$5.477M $6.483M
YoY Change 1638.73% -31.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37260000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32756000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37184000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32681000
dei Entity Central Index Key
EntityCentralIndexKey
0000724742
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1
CY2021Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1
CY2022Q3 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
1
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
1
CY2022Q3 tphs Special Stock Value
SpecialStockValue
CY2021Q4 tphs Special Stock Value
SpecialStockValue
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08546
dei Entity Registrant Name
EntityRegistrantName
TRINITY PLACE HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-2465228
dei Entity Address Address Line1
EntityAddressAddressLine1
340 Madison Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10173
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
235-2190
dei Security12b Title
Security12bTitle
Common Stock $0.01 Par Value Per Share
dei Trading Symbol
TradingSymbol
TPHS
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36907862
CY2022Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
65346000
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
67334000
CY2022Q3 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
201240000
CY2021Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
216983000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2190000
CY2021Q4 us-gaap Assets
Assets
341170000
CY2022Q3 us-gaap Loans Payable
LoansPayable
191870000
CY2021Q4 us-gaap Loans Payable
LoansPayable
219249000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
84000
CY2022Q3 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
123000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4310000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9482000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20535000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5957000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4126000
CY2022Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
4494000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
17938000
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
78000
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
114000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1039000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1314000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7877000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8432000
CY2022Q3 us-gaap Assets
Assets
297826000
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
33584000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
32844000
CY2022Q3 us-gaap Secured Debt
SecuredDebt
9750000
CY2021Q4 us-gaap Secured Debt
SecuredDebt
12750000
CY2022Q3 us-gaap Notes Payable
NotesPayable
5863000
CY2021Q4 us-gaap Notes Payable
NotesPayable
5863000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16659000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
17864000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1141000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1447000
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
151000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1146000
CY2022Q3 us-gaap Liabilities
Liabilities
259018000
CY2021Q4 us-gaap Liabilities
Liabilities
291163000
CY2022Q3 tphs Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2021Q4 tphs Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1
CY2021Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
79999997
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
79999997
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43417662
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43024424
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36877140
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36626549
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
434000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
430000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
144725000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
144282000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6540522
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6397875
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
57461000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
57166000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-987000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1343000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47903000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36196000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
38808000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
50007000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
297826000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
341170000
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1477000
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
967000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3968000
CY2022Q3 us-gaap Other Income
OtherIncome
20000
CY2021Q3 us-gaap Other Income
OtherIncome
30000
us-gaap Other Income
OtherIncome
46000
us-gaap Other Income
OtherIncome
332000
CY2022Q3 tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
17509000
CY2021Q3 tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
1428000
tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
28696000
tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
1428000
CY2022Q3 us-gaap Revenues
Revenues
19006000
CY2021Q3 us-gaap Revenues
Revenues
2425000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1991000
us-gaap Revenues
Revenues
32710000
us-gaap Revenues
Revenues
3751000
CY2022Q3 tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
1220000
CY2021Q3 tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
897000
tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
2790000
tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
4692000
CY2022Q3 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
486000
CY2021Q3 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
271000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
1292000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
429000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1431000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1440000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4436000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4070000
CY2022Q3 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
158000
CY2021Q3 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
158000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
473000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
483000
CY2022Q3 tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
16714000
CY2021Q3 tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
1395000
tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
27238000
tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
1395000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1006000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1001000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3013000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3001000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
21015000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5162000
us-gaap Operating Expenses
OperatingExpenses
39242000
us-gaap Operating Expenses
OperatingExpenses
14070000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2009000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2737000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6532000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10319000
CY2022Q3 tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-14000
tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
802000
tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-636000
tphs Income Loss From Equity Method Investments Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsGainOnSaleOfProperty
4490000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-64000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1577000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1718000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-995000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
192000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3549000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2367000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9613000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5014000
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
763000
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
269000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1213000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6271000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3655000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11435000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17374000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-47000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
272000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6353000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3608000
us-gaap Net Income Loss
NetIncomeLoss
-11707000
us-gaap Net Income Loss
NetIncomeLoss
-17461000
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
119000
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
119000
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
356000
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
356000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6234000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3489000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11351000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17105000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37260000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32756000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37184000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32681000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44897000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6353000
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-119000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
145000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
38808000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
50007000
us-gaap Net Income Loss
NetIncomeLoss
-11707000
tphs Shares Issued Value Settlement Of Stock Awards
SharesIssuedValueSettlementOfStockAwards
-291000
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-356000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
443000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
38808000
tphs Shares Issued Value Settlement Of Stock Awards
SharesIssuedValueSettlementOfStockAwards
-370000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
48386000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3608000
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-119000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
166000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
178000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
45241000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
62020000
us-gaap Net Income Loss
NetIncomeLoss
-17461000
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-356000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
167000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
529000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
45241000
us-gaap Profit Loss
ProfitLoss
-11707000
us-gaap Profit Loss
ProfitLoss
-17461000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4590000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4214000
us-gaap Share Based Compensation
ShareBasedCompensation
407000
us-gaap Share Based Compensation
ShareBasedCompensation
399000
tphs Gain On Sale Of Joint Venture Real Estate
GainOnSaleOfJointVentureRealEstate
4490000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20000
tphs Reduction Of Claims Liability
ReductionOfClaimsLiability
-356000
tphs Reduction Of Claims Liability
ReductionOfClaimsLiability
-356000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-995000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
192000
tphs Income Loss From Equity Method Investments Cash Flow
IncomeLossFromEquityMethodInvestmentsCashFlow
802000
tphs Income Loss From Equity Method Investments Cash Flow
IncomeLossFromEquityMethodInvestmentsCashFlow
-636000
tphs Distribution Of Cumulative Earnings From Unconsolidated Joint Venture
DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture
1318000
tphs Distribution Of Cumulative Earnings From Unconsolidated Joint Venture
DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture
686000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
243000
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-17259000
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
25371000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-6000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-887000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2209000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
846000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3104000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5775000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6828000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30796000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
93000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
84000
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
17418000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17325000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84000
tphs Proceeds From Loans And Corporate Facility
ProceedsFromLoansAndCorporateFacility
7851000
tphs Proceeds From Loans And Corporate Facility
ProceedsFromLoansAndCorporateFacility
82318000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
500000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4200000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2442000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11672000
tphs Repayments Of Loans
RepaymentsOfLoans
41886000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
291000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
370000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
167000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37326000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27460000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13173000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3420000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24845000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16069000
tphs Repayments Of Loans
RepaymentsOfLoans
56413000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
3500000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12649000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4310000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6515000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20535000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9554000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24845000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16069000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2190000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
917000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9482000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11732000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11672000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12649000
us-gaap Interest Paid Net
InterestPaidNet
9624000
us-gaap Interest Paid Net
InterestPaidNet
13329000
us-gaap Income Taxes Paid
IncomeTaxesPaid
341000
us-gaap Income Taxes Paid
IncomeTaxesPaid
189000
tphs Capitalized Amortization Of Deferred Financing Costs And Lease Commissions
CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions
1480000
tphs Capitalized Amortization Of Deferred Financing Costs And Lease Commissions
CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions
2169000
tphs Capitalized Stock Based Compensation Expense
CapitalizedStockBasedCompensationExpense
36000
tphs Capitalized Stock Based Compensation Expense
CapitalizedStockBasedCompensationExpense
97000
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 – Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Trinity Place Holdings Inc., which we refer to in these financial statements as “Trinity,” “we,” “our,” or “us,” is a real estate holding, investment, development and asset management company. Our largest asset is currently a property located at 77 Greenwich Street in Lower Manhattan (“77 Greenwich”), which is nearing completion of development as a mixed-use project consisting of a 90-unit residential condominium tower, retail space and a New York City elementary school. We also own a recently built 105-unit, 12-story multi-family property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street in Brooklyn, New York (“237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), and, through a joint venture, a 10% interest in a recently built 234-unit multi-family property at 250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> street in Brooklyn, New York (“250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), as well as a property occupied by retail tenants in Paramus, New Jersey. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We also control a variety of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (“Syms”), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and An Educated Consumer is Our Best Customer® slogan. In addition, we had approximately $268.0 million of federal net operating loss carryforwards (“NOLs”) at September 30, 2022, which can be used to reduce our future taxable income and capital gains.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Management’s Plans and Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As a result of the COVID-19 pandemic, numerous federal, state, local and foreign governmental authorities issued a range of “stay-at-home orders”, proclamations and directives aimed at minimizing the spread of COVID-19, among other restrictions on businesses and individuals. The outbreak and restrictions adversely affected our business operations including, among other things, a temporary suspension of construction work at our most significant asset, 77 Greenwich, and the temporary closing of the sales center for the 77 Greenwich residential condominium units as well as the temporary suspension of the remediation work being performed on 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The current economic downturn and volatility in financial markets appear to have been primarily driven by uncertainties associated with a spike in interest rates and a historically high inflation rate. As it relates to our business, these uncertainties include, but are not limited to, the adverse effect of the pandemic on the New York City and broader economy, residential and potential residential sentiment in New York City, particularly Manhattan, as well as lending institutions, construction and material supply partners. The economic downturn has adversely affected our short-term, and may adversely affect our long-term, liquidity, cash flows and revenues and has required and may continue to require significant actions in response, including, but not limited to, reducing or discounting prices for our residential condominium units more than originally budgeted, seeking loan extensions and covenant modifications and, during the pandemic, modifying, eliminating or deferring rent payments in the short term for tenants in an effort to mitigate financial hardships.   </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The ultimate impact of the economic downturn on our operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, but are anticipated to continue to have an adverse impact on our business, financial condition and results of operations, which has been and may continue to be material. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Although the impacts of the pandemic, as well as, more recently, the war in Ukraine, rising interest rates, and high inflation rates have impeded the sale of residential condominium units at 77 Greenwich, we have closed on 25 residential condominium units as of September 30, 2022 and an additional three units since the end of the third quarter ended September 30, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. Given the impacts of COVID-19 and supply-chain issues, while construction at 77 Greenwich is in the final stage of completion, it has taken longer than projected. As a result, certain items were not completed by the Final Completion milestone of September 28, 2022 as contemplated under our 77 Mortgage Loan and mezzanine loan. Missing this deadline was an event of default under the 77 Mortgage Loan and mezzanine loan facility, creating substantial doubt </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">about our ability to continue as a going concern.  Management has held discussions with our 77 Mortgage Lender and is in the process of documenting an amendment to the 77 Mortgage Loan agreement and the mezzanine loan to extend the Final Completion milestone. If we are not successful in completing the amendment, and the 77 Mortgage Lender or the lender under our mezzanine loan facility accelerated their respective loan, cross-defaults would also exist and we would have insufficient cash and liquidity to service our debt and pay operating expenses and other obligations.  The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to our ability to continue as a going concern. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As of September 30, 2022, we had total cash and restricted cash of $11.7 million, of which approximately $2.2 million was cash and cash equivalents and approximately $9.5 million was restricted cash as well as $3.0 million available under our secured line of credit. At this time, we believe our existing balances of cash and cash equivalents, secured line of credit availability, planned refinancing of the Paramus line of credit or sale of the Paramus property and sales of the larger, higher floor condominium units at 77 Greenwich will be sufficient to satisfy our working capital needs and projected capital and other expenditures associated with our operations over the next 12 months, unless we are unable to reach agreement with our lenders as described above. Additionally, management continues to evaluate opportunities to raise capital through sales of equity, including under our ATM program, debt issuances or refinancings, including refinancing the property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, and continues to evaluate dispositions of other properties or other assets and/or sales of partial interests in properties. In addition, management is actively engaging with parties who have expressed interest in the Company’s assets and attributes, and may consider from time to time potential strategic transactions, including acquisition, disposition, and financing and refinancings.  Facts and circumstances that are outside of management’s control could change in the future, and the impact of such matters on residential sentiment in New York City in particular. </p>
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11700000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2200000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9500000
CY2022Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
3000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">c.   <i style="font-style:italic;">Use of Estimates</i> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates.</p>
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">e.    <i style="font-style:italic;">Concentrations of Credit Risk</i> - Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. We hold substantially all of our cash and cash equivalents in banks. Such cash balances at times exceed federally insured limits.</p>
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q3 tphs Aggregate Fees Paid By Sca To Company
AggregateFeesPaidByScaToCompany
46200000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">s<span style="color:#242424;font-family:'Segoe UI';font-size:10.5pt;">.</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><i style="font-style:italic;">Reclassifications - </i>Certain reclassifications have been made to enhance comparability and consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.</p></td></tr></table>
CY2022Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
51141000
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
51141000
CY2022Q3 us-gaap Tenant Improvements
TenantImprovements
221000
CY2021Q4 us-gaap Tenant Improvements
TenantImprovements
200000
CY2022Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
847000
CY2021Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
775000
CY2022Q3 us-gaap Land And Land Improvements
LandAndLandImprovements
28847000
CY2021Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
28847000
CY2022Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
81056000
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
80963000
CY2022Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
15710000
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
13629000
CY2022Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
65346000
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
67334000
CY2022Q3 us-gaap Depreciation
Depreciation
695000
CY2021Q3 us-gaap Depreciation
Depreciation
693000
us-gaap Depreciation
Depreciation
2100000
us-gaap Depreciation
Depreciation
2100000
tphs Percentage Of Property Leased
PercentageOfPropertyLeased
1
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11100000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11100000
tphs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
3200000
CY2021 tphs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
2700000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
185000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
185000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
555000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
555000
CY2022Q3 tphs Remaining Fees To Be Paid By Sca To Company
RemainingFeesToBePaidByScaToCompany
390000
CY2022Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
2401000
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
673000
CY2022Q3 tphs Deferred Finance Costs
DeferredFinanceCosts
2184000
CY2021Q4 tphs Deferred Finance Costs
DeferredFinanceCosts
2184000
CY2022Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
3217000
CY2021Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
2736000
CY2022Q3 tphs Prepaid Expense And Other Assets Gross
PrepaidExpenseAndOtherAssetsGross
7802000
CY2021Q4 tphs Prepaid Expense And Other Assets Gross
PrepaidExpenseAndOtherAssetsGross
5593000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1845000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1467000
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
5957000
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
4126000
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4900000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3800000
CY2022Q3 tphs Maximum Number Of Board Committees In Which Designee Can Sit
MaximumNumberOfBoardCommitteesInWhichDesigneeCanSit
3
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
210287000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
35750000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
246037000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4970000
CY2022Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
241067000
CY2022Q3 tphs Federal Net Operating Loss Carryforwards Utilized To Date
FederalNetOperatingLossCarryforwardsUtilizedToDate
20100000
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74800000
CY2022Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1383000
CY2022Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
4932000
CY2021Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
5473000
us-gaap Interest Costs Incurred
InterestCostsIncurred
13759000
us-gaap Interest Costs Incurred
InterestCostsIncurred
15743000
CY2021Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
3106000
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
4146000
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
10728000
us-gaap Interest Income Other
InterestIncomeOther
1000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3549000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2367000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9613000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5014000
CY2022Q3 tphs Capital Stock Shares Authorized
CapitalStockSharesAuthorized
120000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
79999997
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1
CY2022Q3 tphs Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43417662
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43024424
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36877140
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36626549
CY2019Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7179000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.50
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.31
CY2019Q4 tphs Warrant Agreement Threshold Minimum Beneficial Ownership Percentage
WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage
0.05
CY2019Q4 tphs Warrant Agreement Threshold Maximum Percentage Of Issued And Outstanding Common Stock After Exercise Of Warrants
WarrantAgreementThresholdMaximumPercentageOfIssuedAndOutstandingCommonStockAfterExerciseOfWarrants
0.199
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
151000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1100000
tphs Unrealized Gain Loss On Warrants
UnrealizedGainLossOnWarrants
995000
tphs Unrealized Gain Loss On Warrants
UnrealizedGainLossOnWarrants
-192000
CY2022Q3 tphs Warrant Holder S Right Number Of Board Members To Appoint
WarrantHolderSRightNumberOfBoardMembersToAppoint
1
tphs Warrant Agreement Preemptive Rights Period
WarrantAgreementPreemptiveRightsPeriod
P5Y
CY2022Q3 tphs Warrant Agreement Threshold Minimum Beneficial Ownership Percentage
WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage
0.05
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000.0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
250197
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
483361
tphs Stock Repurchase Program Average Price Per Share
StockRepurchaseProgramAveragePricePerShare
1.93
CY2022Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4500000
CY2022Q3 tphs Special Stock Shares Authorized
SpecialStockSharesAuthorized
1
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1569449
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
548370
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
0
tphs Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1500000
CY2021 tphs Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized
0
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
105065
us-gaap Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
1.43
CY2021 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
107754
CY2021 us-gaap Deferred Compensation Arrangement With Individual Exercise Price
DeferredCompensationArrangementWithIndividualExercisePrice
1.77
tphs Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployee
60500
tphs Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployeeWeightedAverageGrantDateFairValue
1.68
CY2021 tphs Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployee
0
CY2021 tphs Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployeeWeightedAverageGrantDateFairValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1131743
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1569449
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2022Q3 tphs Deferred Compensation Arrangement With Individual Shares Outstanding
DeferredCompensationArrangementWithIndividualSharesOutstanding
389978
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
4500000
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
77000
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
272000

Files In Submission

Name View Source Status
0001558370-22-017866-index-headers.html Edgar Link pending
0001558370-22-017866-index.html Edgar Link pending
0001558370-22-017866.txt Edgar Link pending
0001558370-22-017866-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tphs-20220930.xsd Edgar Link pending
tphs-20220930x10q.htm Edgar Link pending
tphs-20220930xex31d1.htm Edgar Link pending
tphs-20220930xex31d2.htm Edgar Link pending
tphs-20220930xex32d1.htm Edgar Link pending
tphs-20220930xex32d2.htm Edgar Link pending
tphs-20220930_cal.xml Edgar Link unprocessable
tphs-20220930_def.xml Edgar Link unprocessable
tphs-20220930_lab.xml Edgar Link unprocessable
tphs-20220930_pre.xml Edgar Link unprocessable
tphs-20220930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable